SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000200406-23-000005
Filing Date
2023-01-24
Accepted
2023-01-24 07:44:10
Documents
18
Period of Report
2023-01-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20230124.htm   iXBRL 8-K 50133
2 EX-99.1 a2022q4exhibit991.htm EX-99.1 56137
3 EX-99.2 a2022q4exhibit992.htm EX-99.2 1377261
8 a4q22overallfinancialresul.jpg GRAPHIC 55591
9 a4q22regionalfinancialresu.jpg GRAPHIC 24984
10 a4q22salesbysegment.jpg GRAPHIC 29035
  Complete submission text file 0000200406-23-000005.txt   1906689

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20230124.xsd EX-101.SCH 3344
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20230124_def.xml EX-101.DEF 16876
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20230124_lab.xml EX-101.LAB 34315
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20230124_pre.xml EX-101.PRE 17676
12 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20230124_htm.xml XML 19993
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0101
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 23545874
SIC: 2834 Pharmaceutical Preparations